119 related articles for article (PubMed ID: 7689364)
1. Evaluation of the antineoplastic activity of adozelesin alone and in combination with 5-aza-2'-deoxycytidine and cytosine arabinoside on DLD-1 human colon carcinoma cells.
Côté S; Momparler RL
Anticancer Drugs; 1993 Jun; 4(3):327-33. PubMed ID: 7689364
[TBL] [Abstract][Full Text] [Related]
2. Synergistic and additive combinations of several antitumor drugs and other agents with the potent alkylating agent adozelesin.
Smith KS; Folz BA; Adams EG; Bhuyan BK
Cancer Chemother Pharmacol; 1995; 35(6):471-82. PubMed ID: 7533669
[TBL] [Abstract][Full Text] [Related]
3. Comparison of antineoplastic activity of cytosine arabinoside and 5-aza-2'-deoxycytidine against human leukemic cells of different phenotype.
Momparler RL; Onetto-Pothier N; Momparler LF
Leuk Res; 1990; 14(9):755-60. PubMed ID: 1700231
[TBL] [Abstract][Full Text] [Related]
4. Activation of the retinoic acid receptor beta gene by 5-aza-2'-deoxycytidine in human DLD-1 colon carcinoma cells.
Côté S; Momparler RL
Anticancer Drugs; 1997 Jan; 8(1):56-61. PubMed ID: 9147612
[TBL] [Abstract][Full Text] [Related]
5. Studies on the mechanism of the synergistic interaction between 2'-deoxy-5-azacytidine and cisplatin.
Abbruzzese JL; Frost P
Cancer Chemother Pharmacol; 1992; 30(1):31-6. PubMed ID: 1375133
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic and DNA methylation studies of high-dose 1-beta-D-arabinofuranosyl cytosine before and after in vivo 5-azacytidine treatment in pediatric patients with refractory acute lymphocytic leukemia.
Avramis VI; Mecum RA; Nyce J; Steele DA; Holcenberg JS
Cancer Chemother Pharmacol; 1989; 24(4):203-10. PubMed ID: 2473850
[TBL] [Abstract][Full Text] [Related]
7. Adozelesin, a selected lead among cyclopropylpyrroloindole analogs of the DNA-binding antibiotic, CC-1065.
Li LH; Kelly RC; Warpehoski MA; McGovren JP; Gebhard I; DeKoning TF
Invest New Drugs; 1991 May; 9(2):137-48. PubMed ID: 1874598
[TBL] [Abstract][Full Text] [Related]
8. Demethylation by 5-aza-2'-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor beta gene in human colon carcinoma cells.
Côté S; Sinnett D; Momparler RL
Anticancer Drugs; 1998 Oct; 9(9):743-50. PubMed ID: 9840718
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy of L1210 and L1210/ARA-C leukemia with 5-aza-2'-deoxycytidine and 3-deazauridine.
Momparler RL; Momparler LF
Cancer Chemother Pharmacol; 1989; 25(1):51-4. PubMed ID: 2480188
[TBL] [Abstract][Full Text] [Related]
10. Antineoplastic action of 5-aza-2'-deoxycytidine and phenylbutyrate on human lung carcinoma cells.
Boivin AJ; Momparler LF; Hurtubise A; Momparler RL
Anticancer Drugs; 2002 Sep; 13(8):869-74. PubMed ID: 12394273
[TBL] [Abstract][Full Text] [Related]
11. Pilot phase I-II study on 5-aza-2'-deoxycytidine (Decitabine) in patients with metastatic lung cancer.
Momparler RL; Bouffard DY; Momparler LF; Dionne J; Belanger K; Ayoub J
Anticancer Drugs; 1997 Apr; 8(4):358-68. PubMed ID: 9180389
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative effects and DNA hypomethylation by 5-aza-2'-deoxycytidine in human neuroblastoma cell lines.
Carpinelli P; Granata F; Augusti-Tocco G; Rossi M; Bartolucci S
Anticancer Drugs; 1993 Dec; 4(6):629-35. PubMed ID: 7507741
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
[TBL] [Abstract][Full Text] [Related]
14. Comparative activity of the cyclopropylpyrroloindole compounds adozelesin, bizelesin and carzelesin in a human tumor colony-forming assay.
Hidalgo M; Izbicka E; Cerna C; Gomez L; Rowinsky EK; Weitman SD; Von Hoff DD
Anticancer Drugs; 1999 Mar; 10(3):295-302. PubMed ID: 10327036
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the antileukemic activity of 5-AZA-2'-deoxycytidine, 1-beta-D-arabinofuranosylcytosine and 5-azacytidine against L1210 leukemia.
Momparler RL; Momparler LF; Samson J
Leuk Res; 1984; 8(6):1043-9. PubMed ID: 6083417
[TBL] [Abstract][Full Text] [Related]
16. The DNA minor groove-alkylating cyclopropylpyrroloindole drugs adozelesin and bizelesin induce different DNA damage response pathways in human colon carcinoma HCT116 cells.
Cao PR; McHugh MM; Melendy T; Beerman T
Mol Cancer Ther; 2003 Jul; 2(7):651-9. PubMed ID: 12883038
[TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of a novel chemotherapeutic agent, Adozelesin, in gynecologic-cancer cell lines.
Nguyen HN; Sevin BU; Averette H; Perras J; Hightower R; Ramos R; Donato D; Penalver M
Cancer Chemother Pharmacol; 1992; 30(1):37-42. PubMed ID: 1586978
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2'-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells.
Shaker S; Bernstein M; Momparler LF; Momparler RL
Leuk Res; 2003 May; 27(5):437-44. PubMed ID: 12620295
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of antineoplastic action of 5-aza-2'-deoxycytidine (Dacogen) and docetaxel (Taxotere) on human breast, lung and prostate carcinoma cell lines.
Hurtubise A; Momparler RL
Anticancer Drugs; 2004 Feb; 15(2):161-7. PubMed ID: 15075673
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of 5-Aza-2'-deoxycytidine and genistein in combination against leukemia.
Raynal NJ; Charbonneau M; Momparler LF; Momparler RL
Oncol Res; 2008; 17(5):223-30. PubMed ID: 18980019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
